Objective. The "stepped care model of pain management" (SCM-PM) prioritizes the role of primary care providers in optimizing pharmacological management and timely and equitable access to patient-centered, evidence-based nonpharmacological approaches, when indicated. Over the past several years, the Veterans Health Administration (VHA) has supported implementation of SCM-PM, but few data exist regarding changes in pain care resulting from implementation. We examined trends in prescribing and referral practices of primary care providers with hypotheses of decreased opioid prescribing, increased nonopioid prescribing, and increased referrals to specialty care for nonpharmacological services.
Introduction
Pain is a common problem among veterans, with as many as 50% of male veterans and 75% of female veterans reporting any pain, while 9.1% of veterans report severe pain [1] [2] [3] [4] . In response to the prevalence and the psychosocial, medical, and economic burdens associated with pain, the Veterans Health Administration (VHA) National Pain Management Strategy was initiated 2018 American Academy of Pain Medicine. This work is written by US Government employees and is in the public domain in the US.
S30
Pain Medicine, 19, 2018, S30-S37 doi: 10.1093/pm/pny094 Original Research Article November 12, 1998 ; it established pain management as a national priority [5] . This led to several national initiatives to change pain care within the VHA (Figure 1 ).
In 2009, the VHA articulated an evidence-based "stepped care model of pain management" (SCM-PM) as the standard of pain care. The model takes a populationbased public health approach, calling for screening, assessment, and management of chronic pain via lowintensity interventions as a first step, followed by more intensive and tailored approaches if patients do not benefit from the initial interventions. The first step uses interdisciplinary patient-aligned care teams (PACTs), comprised of primary care providers, nurses, and other providers in the primary care setting, to manage the most common pain conditions with support from specialists embedded in primary care such as integrated mental health-primary care teams. The second step employs referral to specialty care for pain and related comorbidities including mental health (e.g., management of depressive disorders), clinical health psychology (e.g., pain psychology), rehabilitative medicine (e.g., physical therapy), neurology (e.g., headache management), and pain medicine (e.g., injections). The third step employs tertiary interdisciplinary care, including advanced pain medicine diagnostics and interventions (e.g., evaluation for implantable therapies) and interdisciplinary pain rehabilitation [6] .
Over the past several years, the VHA has supported the implementation of the SCM-PM by several national, regional, and local (i.e., facility level) initiatives. Of particular relevance is a series of ongoing education and training initiatives and evidence-based clinical practice guidelines designed to enhance the competencies of PACTs to assess and manage most common pain conditions. A VHA version of the widely-praised Extension of Community Healthcare Outcomes (ECHO) [7, 8] was introduced in 2011. ECHO uses remotely accessed learning targeting primary care providers, particularly those in rural community-based clinics. The New England region of the VHA (VISN1) and VA Connecticut Healthcare System (VACHS) also implemented changes to enhance pain management (Figure 2 ). For example, in 2009, pain champions were introduced at a VISN level, while primary care pain workgroups began meeting at VACHS to determine ways to enhance pain management.
Beginning in 2010, a partnership-based project involving the VHA Pain Management Program office, local facility clinical and administrative leaders, and private foundations was established at VACHS. The primary objective of this project, named "Project STEP," was to employ a formative evaluation and implementation approach to promote organizational improvements in pain care consistent with the SCM-PM. The project focused on building capacity to provide high-quality pain care in primary care settings while also enhancing access to specialty care pain management services.
Informed by pre-implementation qualitative and quantitative assessments [9] [10] [11] [12] [13] , the Project STEP team worked to develop the knowledge and competencies of primary care providers and PACTs about a biopsychosocial model of pain and the conduct of comprehensive pain assessments that inform multimodal and interdisciplinary plans of care. To do so, VACHS implemented several changes, such as providing pain-related educational and training opportunities and clinical support resources (e.g., lists of available specialty pain care services, access to online educational resources) for primary care providers and nurses. After conducting a Rapid Process Improvement Workshop engaging stakeholders in primary care, specialty care, and research, two new clinical services were embedded in primary care. One service, called the Integrated Pain Clinic, addressed observed inefficiencies at the interface of primary and specialty care at VACHS in which primary care providers were directing referrals to specialists without first conducting an appropriate assessment that could inform the most appropriate referral. This new clinic conducted interdisciplinary assessments and provided recommendations for veterans with complex chronic pain, including targeted referrals to specialty care. A second clinic was designed to assess and provide [14] treatment for veterans identified as receiving high-risk opioid therapy [15] .
A prior publication reported on patient-level uptake of nonopioid pharmacological and nonpharmacological approaches and opioid risk mitigation strategies for a cohort of veterans who were in receipt of long-term opioid therapy in each of the first four years of the project [13] . In the current study, we examine a broader cohort of veterans with moderate to severe pain and elaborate on similar patient-level outcomes for the full five years of Project STEP. We also examined differences in trends for all outcomes of interest between this cohort of veterans with at least moderate pain severity and a cohort comprised of all other veterans seen at least once in primary care during the study period (i.e., veterans with no indication of moderate to severe pain). Our objective was to examine trends in prescribing and referral practices of primary care providers with a specific hypothesis of decreased opioid prescribing, increased nonopioid prescribing, and increased referrals to specialty care for nonpharmacological services. We also examined trends in receipt of specialty care as an indication of enhanced access.
Methods
We compared VACHS veteran patients who reported moderate to severe pain with all other veterans seen in primary care. We examined referral patterns and use of pain care-related services and prescriptions over a fiveyear period from July 2008 to June 2013. Electronic health record (EHR) data were extracted from the Corporate Data Warehouse for all primary care patients (44,500/year). Extracted data included demographic variables (age, sex), pain intensity ratings, and health care utilization outcomes, including primary care visits and referrals and visits to specialty pain care services. We also extracted pharmacy data for all prescriptions filled through VACHS during the study period regardless of prescriber or time frame of visit.
Facility Description
VACHS is an integrated system of care that includes a tertiary care hub with inpatient and outpatient facilities, a second large outpatient facility, and six communitybased outpatient clinics. In each of the five years analyzed, the sample consisted of all veterans at VACHS. Veterans in the "pain cohort" were those who had one or more documented pain intensity ratings indicative of at least moderate severity (i.e., pain intensity rating of 4 or greater on a 0 [no pain] to 10 [worst pain imaginable] numeric rating scale [16, 17] ) associated with a primary care visit during that study year. Veterans could be in the cohort for multiple years. Veterans in the "nonpain cohort" were all veterans seen in primary care with no visits with a pain intensity rating of 4 or greater. Thus, this cohort included veterans with no indication of pain and veterans reporting only mild pain intensity (pain intensity ratings of 1-3). There were no patient exclusion criteria.
Measures

Medication
We used pharmacy data to determine prescriptions for sedative/hypnotic medications, topical analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), antidepressants, anticonvulsants, and opioids. Use of long-term opioid therapy was defined as receipt of at least 90 consecutive days of prescriptions in the EHR for VHA class CN101 drugs, which include codeine, fentanyl, hydrocodone, methadone, morphine, oxycodone, oxymorphone, and hydromorphone; we excluded buprenorphine and methadone prescribed for opioid use disorder.
Health Care Utilization
Health care utilization outcomes were documented mental health, clinical health psychology, physical therapy, occupational therapy, neurology, pain medicine, and chiropractic referrals from primary care providers and visits in these specialty care clinics. We examined whether the provider placed a referral for a specialty service (i.e., that provider recommended and approved the service for the patient) as well as whether the veteran attended the service and the number of visits with that service. We also examined frequency of primary care visits.
Multimodal Care
Based on definitions used by other VHA researchers [18] and consistent with recent guidelines regarding the management of chronic pain and comorbid conditions [19, 20] , we examined the proportion of veterans receiving multimodal pain care, defined as receiving both a nonopioid pain medication and at least one encounter with a relevant specialty service.
Statistical Analyses
We used descriptive statistics to characterize both the pain and nonpain cohorts. To examine differences in health care utilization outcomes over the five-year time frame, we used general estimating equations (GEE) logit-linked, logistic regression models with robust variance estimation and intercept, controlling for patients nested within providers, and patient age and sex [21, 22] . Statistical values presented in the tables are for Wald X 2 s from the final models. We evaluated different working correlation structures and selected models with the best fit based on quasiinformation criterion (QIC) criteria. For all but one model (pain medicine visits), the autoregressive 1 (AR1) model provided the best fit. Referrals and visits were evaluated as independent measures because visits during a specified year did not require a referral for that year and patients seen previously in a given specialty (e.g., mental health) could request new visits without a referral. Because the different specialties and nonopioid medications were subcategories of the overall measures of referrals, visits, or nonopioid medication, we used Bonferroni correction to account for the multiple measures, resulting in a test level alpha ¼ 0.0083 (0.05/6) for consults, alpha ¼ 0.0071 (0.05/7) for visits, and alpha ¼ 0.01 (0.05/5) for alternative medications. All analyses were conducted in SAS 9.2 (SAS Institute Inc., Cary, NC, USA).
Results
Cohort Descriptions
In each year of Project STEP, there were between 11,601 and 15,099 veterans who met criteria for inclusion in the pain cohort; of the 65,053 pain cohort observations over the five years, there were 31,286 unique veteran patients who had at least one visit with a documented pain intensity rating of 4 or greater. Table 1 presents descriptive and demographic information on the pain and nonpain cohorts. The proportion of women in VACHS increased over the five-year period, and women were more likely to be in the pain cohort (7.2%) than not (3.7%) (X 2 (1) ¼ 1180.12, P < .0001). Mean age decreased slightly over the five-year period (X 2 (4) ¼ 22.00, P < 0.0001), and patients in the cohort were significantly younger than those who were not (68.4 vs 62.1 years; F(1) ¼ 7250.91, P < .0001). Among members of the pain cohort, the mean pain intensity rating (SD) was 6.5 (1.7) in year 1 and increased to 6.8 (1.7) in year 5. Controlling for age and sex, over the course of the study period, the number of patients who met criteria for inclusion into the cohort increased each year, from 29.7% in year 1 to 37.1% in year 5. Pain cohort patients were seen significantly more frequently in primary care than those not in the pain cohort (3.4 vs 2.2 visits, respectively). The overall mean number of primary care visits for all patients was 2.6 visits per year.
Analgesic Use
We examined use of prescription medications that are commonly used for pain control (Table 2) , which were classified as opioids, sedative/hypnotics, topical analgesics, NSAIDs, antidepressants, or anticonvulsants. It is important to acknowledge that sedative/hypnotics, antidepressants, and anticonvulsants are also commonly used for management of other disorders. The data did not specify the diagnosis for the prescription. As demonstrated in Table 2 , within the pain cohort, long-term opioid therapy (> 90 days) decreased from 4.2% in year 1 to 3.3% in year 5, while nonopioid medication prescriptions increased (36.7% to 39.8%).
Health Care Utilization
In addition to examining prescription medication use, we examined changes in referral patterns and visits with specialty services. Table 3 provides the estimated yearly percentages from the GEE logistic regression models controlling for age and sex, the estimated chi-square value, and P values over time. Overall, the number of referrals to specialty services increased over the five-year time period for the pain cohort, but, as one might expect, little change was observed for those not in the pain cohort. Although there were no differences observed for mental health or chiropractic referrals, a clear pattern of increase for those in the pain cohort, with limited change for the nonpain cohort, was found for physical therapy and occupational therapy, particularly in the final two years. Neurology and pain medicine consults showed a similar pattern, but the size of these changes was particularly modest (10.3% to 10.7%, and 3.2% to 3.8%, respectively). The number of veterans with at least one documented encounter in a specialty service increased from 43.4% in year 1 to 51.8% in year 5. As can be seen in the specific subspecialties in Table 2 , the pattern of substantial increases (>30%) for the pain cohort was observed for clinical health psychology, physical therapy, occupational therapy, chiropractic, and neurology. Although the findings were significant for both mental health and pain medicine, the difference was less substantial.
Finally, we were interested in the number of veterans receiving at least one nonopioid pain medication and one Multimodal pain care was defined as receiving both a nonopioid pain medication and at least one encounter with a specialty pain care service.
referral to a specialty care service as an indication of receipt of multimodal pain care (Table 3 ). The proportion of veterans receiving a nonopioid pain medication and a referral to specialty pain care services increased from 24.5% in year 1 to 29.0% in year 5.
Discussion
Over a five-year period, a number of changes consistent with the SCM-PM were implemented to build the capacity for pain management in primary care and improve the interface between primary care and specialty services. During this time frame, we observed an increase in the proportion of veterans reporting moderate to severe pain, perhaps due to an increase in the proportion of younger veterans and women veterans, groups known to report higher-than-average rates of pain [1] [2] [3] [4] 23] . We also saw increases in the use of nonopioid medications for pain.
This overall increase appears to be driven by an increase in the use of topical analgesics, NSAIDs, and anticonvulsant medications, while some other medication types (e.g., sedative/hypnotics) saw an overall decline in prescribing. We also observed significant decreases in the proportion of patients receiving long-term opioid therapy; overall, this suggests a reduced reliance on opioids for pain management, suggesting a possible increase in evidenced-based prescribing for pain in our facility. As such, the strategies used at VACHS may be useful to other health care systems. Consistent with recommendations from multiple groups encouraging multimodal pain care, we found increased referrals to and receipt of several different painrelevant specialty services over time. At the same time, about half of all veterans reporting moderate to severe pain were not seen for pain outside of primary care, perhaps indicating that our efforts to build the capacity for pain management within primary care were successful. Indeed, by year 5, veterans in the cohort were seen on average 3.4 times per year in primary care, which is higher than the overall VACHS average. Moreover, while receipt of specialty services increased for many specialties, we did not find clinically significant differences in the mean number of visits each veteran had with specialty services (even when the number of visits declined, it was typically by 1 visit per patient or less). These observations suggest that the increase in the number of referrals did not compromise continued access to care in these specialty care settings.
Overall, the proportion of veterans in the pain cohort receiving a combination of nonopioid pharmacological treatments and being seen by at least one pain-relevant specialty service increased from 24.5% in year 1 to 29.0% in year 5. Most guidelines for the management of pain now encourage the use of both nonopioid pharmacological and nonpharmacological pain management strategies, and some experts in the field have used the combination of nonopioid pharmacological and nonpharmacological pain management strategies to define guidelineconcordant pain care [18] . This finding suggests an increase in the number of veterans with moderate to severe pain at VACHS receiving guideline-concordant care.
Strengths of this study include the large sample size and our ability to look at a wide range of services for veterans with moderate to severe pain in an entire integrated health care system over the course of five years. We were also able to control for temporal trends by comparing the pain cohort with veterans who never reported moderate to severe pain. Despite these strengths, this study has limitations. We chose to define our cohort as veterans reporting moderate to severe pain during at least one outpatient primary care encounter; this definition did not distinguish presentations of acute vs persistent pain or include veterans with mild pain intensity, nor was information on pain-related diagnoses available. Future work may want to focus on different subsets of patients with pain. For example, less is known about treating veterans with mild pain intensity, as they are often not included in painrelated research, yet they may use pain-related services and may benefit from systems-level interventions such as the one described here. Additionally, some of the specialty pain care services included in our analyses provided services that extend beyond pain. Because we did not examine diagnoses associated with care in these settings, we are limited in our ability to draw firm conclusions about whether pain-specific care was delivered. For example, mental health services may address pain, but may also address a number of mental health concerns that may or may not be relevant to veterans' experience of pain; this is also likely true for some medications we examined as well. Furthermore, while we used a broad definition of one nonopioid pharmacological treatment and one nonpharmacological pain management service to represent multimodal pain care and guideline-concordant care, without more detail regarding veterans' presenting problems and the services they received, it is not possible to determine whether veterans were receiving appropriate services (e.g., some veterans may have presented with acute pain and appropriately received a short-term opioid prescription). Finally, because several changes were implemented at national, regional, and local levels, and changes were implemented throughout VACHS, it was not possible to isolate what caused any specific change; rather, we were only able to examine temporal trends.
Through a multilayered comprehensive implementation within VACHS, primary care providers improved pain care practices by increasing referral and visits for nonpharmacological treatments such as physical and occupational therapy, clinical health psychology, and chiropractic care. Future studies should consider randomized or quasi-randomized designs to isolate the stepped care model's impact on patient-level outcomes, as well as the costs of implementing this approach. Findings suggest that engagement of interdisciplinary teams, including key stakeholder groups and partnerships, to promote organizational improvements is a useful strategy to increase the use of integrated, multimodal care for veterans with pain, consistent with the VHA's SCM-PM.
